[COURSE] CSAMA'06, few places available
0
0
Entering edit mode
stefano iacus ▴ 430
@stefano-iacus-995
Last seen 9.7 years ago
LAST ANNOUNCEMENT: CSAMA'06 Computational and Statistical Aspects of Microarray Analysis (IV) June 18-23 2006, Bressanone-Brixen, Italy This 5 days lecture series provides an introduction to genomic data and their interpretation. The main focus will be on microarray experiments, covering statistical topics such as preprocessing, normalization, quality assessment, gene identification, machine learning and inference for graphs and networks. Applications of these methods to proteomics and other high throughput technologies will also be covered. Computer laboratory material will be available for self-study. Participants should have some minimal background on biological, statistical and computational aspects of microarrays, or other high-throughput data. The maximum number of participants is 60. Participants will receive a copy of the book "Bioinformatics and Computational Biology Solutions Using R and Bioconductor", Gentleman et al., Springer NY, 2005. There are 40 additional places for auditors (lectures only). PLEASE NOTE: REGISTRATION CLOSE ON May 15th 2006. FEW PLACES STILL AVAILABLE Lecturers of the course: * Robert Gentleman, Fred Hutchinson Cancer Research Center, Seattle (WA), USA. * Wolfgang Huber, European Bioinformatics Institute, Cambridge, England (UK). * Zhijin (Jean) Wu, Center for Statistical Sciences, Brown University (USA) The course is organized jointly by Universities of Milan and Padua, Italy in collaboration with the Biocondutor project and the R Foundation for Statistical Computing. For further information, registration and topics please refer to the course web page "http:// www.economia.unimi.it/marray" [apologizes for cross posting]
Microarray Proteomics Preprocessing Cancer Microarray Proteomics Preprocessing Cancer • 1.0k views
ADD COMMENT

Login before adding your answer.

Traffic: 505 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6